New pill could ease Parkinson's symptoms without standard meds
Disease control
Completed
This study tested a new drug called CVN424 in 64 people with early Parkinson's disease who were not yet taking any Parkinson's medications. For 12 weeks, half received CVN424 and half received a placebo. The goal was to see if CVN424 could improve both motor symptoms (like moveme…
Phase: PHASE2 • Sponsor: Cerevance Beta, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC